Arteriovenous Malformations and Epilepsy

How an abnormal tangle of blood vessels can become part of a focal epileptic network

A cerebral arteriovenous malformation (AVM) is an abnormal connection between arteries and veins in which blood bypasses the normal capillary network. AVMs can present with haemorrhage, headache, focal neurological symptoms, or epileptic seizures. Some are discovered incidentally.

When seizures are associated with a cerebral AVM, the epilepsy is usually focal because the epileptic network develops around a particular region of cortex rather than throughout the brain at once.

The presence of an AVM on MRI or angiography does not automatically prove that it is the cause of a person’s seizures. The relationship has to make sense anatomically and clinically.

Why can an AVM cause seizures?

The AVM itself is vascular tissue, not normal cortex. Seizures are thought to arise mainly from the surrounding brain.

Several mechanisms may contribute:

chronic changes in blood flow around the AVM;
gliosis and tissue injury;
small or previous haemorrhages with deposition of blood-breakdown products;
venous hypertension or congestion;
irritation of nearby cortex;
reorganisation of local neural networks over time.

This means the visible vascular nidus and the actual seizure-onset zone are related but not necessarily identical.

Location matters

AVMs close to cerebral cortex are more likely to be associated with seizures than lesions in regions that are less directly connected to cortical networks.

Temporal, frontal, parietal and occipital AVMs can therefore produce different seizure manifestations. A temporal AVM may be associated with altered awareness, experiential symptoms or automatisms. A frontal AVM may cause tonic or hypermotor seizures. AVMs near motor cortex can cause focal jerking, while occipital lesions may produce visual seizure symptoms.

Symptoms can suggest a network, but they do not establish the vascular diagnosis or prove which lesion is responsible.

Seizure as the first presentation

For some people, a first seizure is what leads to imaging and the discovery of an AVM.

That does not mean every first seizure is caused by an AVM. Cerebral AVMs are uncommon, and many people with epilepsy have no vascular malformation.

When an AVM is found after a seizure, clinicians still need to ask whether the lesion is genuinely concordant with the seizure semiology, EEG and surrounding brain findings.

Haemorrhage and epilepsy are different presentations

An AVM can cause a seizure without a recognised major brain haemorrhage.

Conversely, a haemorrhage from an AVM can itself provoke an acute symptomatic seizure and may leave structural injury that later becomes epileptogenic.

These pathways are not identical. Someone can have AVM-related epilepsy without ever having had a known intracranial haemorrhage, while another person may develop seizures only after a bleed.

Acute symptomatic seizure or chronic epilepsy?

If a seizure occurs in close temporal association with an acute AVM haemorrhage, it may initially be classified as an acute symptomatic seizure.

That is different from recurrent unprovoked seizures arising from a chronic epileptogenic network around an AVM.

The distinction matters because it affects prognosis, long-term antiseizure treatment decisions and how clinicians interpret recurrence risk.

What does EEG show?

EEG can show focal epileptiform discharges, focal slowing or more widespread abnormalities depending on the epileptic network and the effects of any previous brain injury.

A normal routine EEG does not exclude AVM-related epilepsy.

Likewise, an abnormal EEG does not automatically prove that the AVM is the source unless the electrical findings fit the lesion and the clinical events.

Longer ambulatory EEG or inpatient video-EEG may be useful when the nature of recurrent events is uncertain.

What does MRI show?

MRI can show the AVM, surrounding gliosis, previous haemorrhage and other structural consequences.

Susceptibility-sensitive sequences can be useful for identifying blood products from previous bleeding.

MRI alone, however, cannot map the full seizure-onset network. See also MRI Lesion Does Not Always Mean Seizure Cause.

Why angiography matters

Catheter cerebral angiography remains an important test for defining AVM vascular anatomy, particularly when treatment is being considered.

It can show the feeding arteries, nidus, venous drainage and high-risk vascular features in much greater detail than routine structural imaging.

This information is central to treatment planning but does not replace epilepsy assessment. Angiography answers a vascular question; EEG and seizure semiology answer electrical and clinical questions.

Does everyone with an AVM need antiseizure medication?

No.

An incidentally discovered AVM in a person who has never had a seizure is not, by itself, a reason to prescribe antiseizure medication.

Once a person has had an unprovoked seizure believed to be caused by an AVM, treatment decisions depend on the recurrence risk, lesion characteristics, treatment plan and individual clinical circumstances.

There is no single antiseizure medicine uniquely suited to AVM-related epilepsy. Drug choice follows the usual principles for focal epilepsy, taking account of age, pregnancy considerations, other illnesses, drug interactions and adverse-effect profile.

Can treating the AVM improve the epilepsy?

Yes, in many people seizure control improves after successful AVM treatment.

A systematic review and meta-analysis of 49 studies including 2,668 patients found that interventional treatment of AVM-associated epilepsy was linked with seizure freedom in about 56% overall and seizure improvement in about 73%. Microsurgery appeared to produce higher seizure-freedom rates than radiosurgery, embolisation or multimodality treatment, although the available evidence was largely observational and direct comparisons were limited.

A separate meta-analysis likewise found the highest complete seizure-free rates after surgical resection compared with stereotactic radiosurgery or embolisation alone.

These figures describe groups, not guarantees for an individual.

Microsurgical resection

Microsurgical removal can eliminate the AVM immediately when complete resection is achieved.

For suitable superficial or lower-grade AVMs, surgery can offer both protection from future AVM haemorrhage and a good chance of improved seizure control.

The seizure result depends on more than simply removing the vascular nidus. Longstanding epilepsy may have produced a broader epileptic network in surrounding cortex.

Surgery also carries risks that depend on AVM size, location, venous drainage and proximity to eloquent brain regions.

Stereotactic radiosurgery

Stereotactic radiosurgery delivers focused radiation to the AVM with the aim of causing progressive vessel closure over time.

Unlike microsurgery, the AVM is not removed immediately. Obliteration can take months or years, and haemorrhage risk persists during that latency period.

Systematic reviews show that many people experience seizure improvement after radiosurgery, and complete AVM obliteration is generally associated with better seizure outcomes than incomplete obliteration in much of the literature.

However, seizure control can improve before angiographic obliteration in some cases, suggesting that radiation-related biological changes may alter local epileptogenicity as well.

Endovascular embolisation

Endovascular embolisation involves passing catheters through the blood vessels and injecting material to reduce or close abnormal AVM channels.

It may be used as a stand-alone treatment in selected cases, but more often it is part of a multimodality strategy before surgery or radiosurgery.

Seizure outcomes after embolisation alone are more variable than after microsurgical resection in published meta-analyses.

New seizures can also occur after treatment if there is haemorrhage, infarction or other procedure-related brain injury.

Treatment is not chosen for epilepsy alone

An AVM is not treated only because of seizure frequency.

The decision also considers haemorrhage risk, AVM size and location, venous drainage pattern, previous bleeding, age, neurological status and the risks of each treatment option.

For unruptured AVMs, treatment decisions can be especially complex because intervention itself carries risk.

Epilepsy is therefore one part of the overall neurovascular decision rather than an isolated reason to choose surgery, radiosurgery or embolisation.

Why complete obliteration matters

When an AVM remains patent, both vascular risk and seizure-related questions remain.

Several radiosurgery studies have found better seizure outcomes after complete obliteration than after incomplete treatment. However, this association is not perfectly consistent across every series.

Seizure freedom can occur without complete obliteration, and seizures can persist despite angiographic cure if an established epileptic network remains in the surrounding brain.

What if seizures continue after the AVM is gone?

Persistent seizures do not necessarily mean the vascular treatment failed.

The AVM may have been completely removed or obliterated while gliosis, previous haemorrhagic injury or an established cortical epileptic network remains.

If seizures continue, reassessment can include repeat EEG, MRI, review of the original seizure semiology and, in selected cases, a specialist epilepsy-surgery work-up.

Can someone still need epilepsy surgery after AVM treatment?

Yes, although this is a specialist situation.

If disabling seizures persist after successful AVM treatment, the epileptogenic zone may extend beyond the original vascular lesion.

In selected people, presurgical evaluation may show a residual focal epileptic network that can be targeted separately.

This is another example of why treating the structural lesion and treating the epilepsy are sometimes overlapping but distinct problems.

Drug-resistant AVM-related epilepsy

If two appropriate and tolerated antiseizure medication schedules fail to produce sustained seizure freedom, the epilepsy meets the usual ILAE definition of drug resistance.

At that point, the person should not simply be cycled indefinitely through medication changes without reconsidering the structural lesion and the possibility of specialist intervention.

Whether intervention is possible depends on AVM anatomy and overall neurological risk.

Pregnancy and reproductive considerations

People with an AVM and epilepsy may need advice that covers both the vascular malformation and antiseizure medication.

Pregnancy can alter haemodynamic conditions, and antiseizure medicines have different reproductive safety profiles.

Management should therefore be individualised through neurology, neurovascular/neurosurgical and obstetric teams where appropriate.

The key distinction

A cerebral AVM is a vascular structural lesion. AVM-related epilepsy is an electrical network disorder that can develop in the surrounding brain.

The two overlap but are not interchangeable.

A person can have an AVM without epilepsy. A seizure can occur because of an acute AVM haemorrhage without chronic epilepsy developing. Complete AVM obliteration can improve seizure control but does not guarantee seizure freedom. And a normal routine EEG does not exclude AVM-related epilepsy.

The most useful clinical model is therefore to consider vascular anatomy, brain injury, seizure semiology, EEG and the surrounding cortical network together.

Sources and further reading

Evidence checked: September 2026.

This page is for general education and does not replace individual advice from a neurologist, neurovascular specialist or neurosurgeon.